New generation DES in treatment of patients with multivessel coronary artery disease. Comparison of one year clinical outcomes of biolimus-eluting (Nobori) and everolimus-eluting (Xience/Promus) stents in COMPARE II study
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Fecha de publicación
2013Título de revista
EuroIntervention
Tipo de contenido
Publicación de congreso
![](/xmlui/themes/Mirage2//images/final_lines.png)